436 related articles for article (PubMed ID: 28267255)
1. A systematic review examining quality of life following pelvic exenteration for locally advanced and recurrent rectal cancer.
Rausa E; Kelly ME; Bonavina L; O'Connell PR; Winter DC
Colorectal Dis; 2017 May; 19(5):430-436. PubMed ID: 28267255
[TBL] [Abstract][Full Text] [Related]
2. Baseline quality of life predicts pelvic exenteration outcome.
Choy I; Young JM; Badgery-Parker T; Masya LM; Shepherd HL; Koh C; Heriot AG; Solomon MJ
ANZ J Surg; 2017 Nov; 87(11):935-939. PubMed ID: 26687437
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
[TBL] [Abstract][Full Text] [Related]
4. [Quality of life after extensive pelvic surgery].
Levý M; Lipská L; Visokai V; Šimša J
Rozhl Chir; 2016; 95(9):358-462. PubMed ID: 27653304
[TBL] [Abstract][Full Text] [Related]
5. Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
Hagemans JAW; Rothbarth J; Kirkels WJ; Boormans JL; van Meerten E; Nuyttens JJME; Madsen EVE; Verhoef C; Burger JWA
Eur J Surg Oncol; 2018 Oct; 44(10):1548-1554. PubMed ID: 30075979
[TBL] [Abstract][Full Text] [Related]
6. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
7. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
Platt E; Dovell G; Smolarek S
Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
[TBL] [Abstract][Full Text] [Related]
9. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
PelvEx Collaborative
Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
[TBL] [Abstract][Full Text] [Related]
11. Bladder preservation or complete cystectomy during pelvic exenteration of patients with locally advanced or recurrent rectal cancer, what should we do?
Palma CA; van Kessel CS; Solomon MJ; Leslie S; Jeffery N; Lee PJ; Austin KKS
Eur J Surg Oncol; 2023 Jul; 49(7):1250-1257. PubMed ID: 36658054
[TBL] [Abstract][Full Text] [Related]
12. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
[TBL] [Abstract][Full Text] [Related]
13. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer.
Vermaas M; Ferenschild FT; Verhoef C; Nuyttens JJ; Marinelli AW; Wiggers T; Kirkels WJ; Eggermont AM; de Wilt JH
Eur J Surg Oncol; 2007 May; 33(4):452-8. PubMed ID: 17071043
[TBL] [Abstract][Full Text] [Related]
14. Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
Colorectal Dis; 2024 May; 26(5):926-931. PubMed ID: 38566456
[TBL] [Abstract][Full Text] [Related]
15. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
[TBL] [Abstract][Full Text] [Related]
16. Impact of nutritional status and body composition on postoperative outcomes after pelvic exenteration for locally advanced and locally recurrent rectal cancer.
van Rees JM; Visser E; van Vugt JLA; Rothbarth J; Verhoef C; van Verschuer VMT
BJS Open; 2021 Sep; 5(5):. PubMed ID: 34672343
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
[TBL] [Abstract][Full Text] [Related]
18. A qualitative study of the development of a multidisciplinary case conference review methodology to reduce involved margins in pelvic exenteration surgery for recurrent rectal cancer.
van Ramshorst GH; O'Shannassy S; Brown WE; Kench JG; Solomon MJ
Colorectal Dis; 2018 Nov; 20(11):1004-1013. PubMed ID: 29920909
[TBL] [Abstract][Full Text] [Related]
19. Quality of life of survivors after pelvic exenteration for rectal cancer.
Austin KK; Young JM; Solomon MJ
Dis Colon Rectum; 2010 Aug; 53(8):1121-6. PubMed ID: 20628274
[TBL] [Abstract][Full Text] [Related]
20. Total pelvic exenteration for locally advanced rectal cancer.
Law WL; Chu KW; Choi HK
J Am Coll Surg; 2000 Jan; 190(1):78-83. PubMed ID: 10625236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]